HIV Opportunistic Infections: Prophylaxis and Treatment

Primary Prophylaxis Regimens

• The American College of Physicians recommends initiating prophylaxis for Pneumocystis Pneumonia (PCP) with Trimethoprim-sulfamethoxazole (TMP-SMX) 800mg/160mg (double-strength) one tablet orally three times weekly when CD4 count <200 cells/μL, and continuing until CD4 count recovers to ≥200 cells/μL for ≥3 months duration after ART initiation 1
• The Centers for Disease Control and Prevention (CDC) suggests alternative prophylaxis for PCP with Dapsone 100 mg orally daily 1
• The Infectious Diseases Society of America (IDSA) recommends Azithromycin 1200 mg orally once weekly for Mycobacterium avium Complex (MAC) prophylaxis when CD4 count <50 cells/μL, and continuing until CD4 count recovers to ≥100 cells/μL for ≥3 months duration post-ART 1

Treatment Considerations for Active Opportunistic Infections

• The Clinical Infectious Diseases journal recommends Nystatin for mild oral/esophageal candidiasis 1
• The American Academy of Family Physicians suggests Fluconazole for moderate-severe candidiasis, but advises avoiding it during pregnancy 2
• The Clinical Infectious Diseases journal recommends TMP-SMX 15-20 mg/kg/day (based on TMP component) divided three times daily for 21 days for Pneumocystis Pneumonia treatment, and adding corticosteroids for moderate-severe disease (PaO2 <70 mmHg) 3

Antiretroviral Therapy as Primary Prevention

• The American Academy of Family Physicians recommends Highly Active Antiretroviral Therapy (HAART) as the most effective approach to preventing opportunistic infections, and suggests considering it for all HIV-infected persons 4, 2
• The Clinical Infectious Diseases journal notes that ART reduces OI incidence by suppressing HIV replication and increasing CD4 counts 3

Discontinuation of Prophylaxis

• The American Academy of Family Physicians recommends discontinuing PCP/Toxoplasmosis prophylaxis when CD4 >200 cells/μL for ≥3 months on ART 4, 2
• The Clinical Infectious Diseases journal suggests discontinuing MAC prophylaxis when CD4 >100 cells/μL for ≥3 months on ART, requiring sustained virologic suppression and immune reconstitution 3

Special Populations

• The American Academy of Family Physicians advises avoiding Fluconazole during pregnancy 2
• The Centers for Disease Control and Prevention (CDC) recommends PCP prophylaxis with TMP-SMX dosing based on weight for children 5, 6

Critical Pitfalls to Avoid

• The Journal of the National Comprehensive Cancer Network recommends not discontinuing prophylaxis prematurely, ensuring sustained CD4 recovery for specified duration 1

CD4 Count and Opportunistic Infections in HIV

Introduction to CD4 Count Thresholds

• The Centers for Disease Control and Prevention recommends that patients with HIV receive prophylaxis for Pneumocystis pneumonia (PCP) when their CD4 count is less than 200 cells/μL 7
• The American Thoracic Society suggests that a CD4 count of 200 cells/μL is a critical threshold for the majority of severe infections in HIV patients 8, 7

Umbrales de CD4 para infecciones oportunistas específicas

• Neumonía por Pneumocystis (PCP) typically requires prophylaxis when the CD4 count is less than 200 cells/μL, as recommended by the Centers for Disease Control and Prevention 7, 9
• Toxoplasmosis cerebral requires prophylaxis when the CD4 count is less than 100 cells/μL in patients with positive IgG antibodies for Toxoplasma, according to the Centers for Disease Control and Prevention 7
• Criptococosis typically occurs with CD4 counts less than 100 cells/μL, as reported by the Centers for Disease Control and Prevention 7
• Histoplasmosis and coccidioidomicosis are more frequent with CD4 counts less than 100 cells/μL, according to the Centers for Disease Control and Prevention 7
• Complejo Mycobacterium avium (MAC) diseminado requires prophylaxis when the CD4 count is less than 50 cells/μL, as recommended by the Centers for Disease Control and Prevention 7

Consideraciones importantes

• La tuberculosis puede ocurrir a cualquier nivel de CD4, aunque el riesgo aumenta significativamente con CD4 counts less than 300 cells/μL, as reported by the Infectious Diseases Society of America 10, 9
• El herpes zóster y las infecciones neumocócicas pueden ocurrir incluso con CD4 counts greater than 200 cells/μL, according to the Infectious Diseases Society of America 10, 11
• El recuento de CD4 sigue siendo el mejor marcador indirecto de la función inmune en pacientes con VIH, as stated by the American College of Chest Physicians 8, 9

Recomendaciones para la práctica clínica

• Iniciar profilaxis contra PCP cuando el recuento de CD4 es menos de 200 células/μL, as recommended by the Centers for Disease Control and Prevention 7
• Iniciar profilaxis contra toxoplasmosis cuando el recuento de CD4 es menos de 100 células/μL en pacientes con anticuerpos IgG positivos, according to the Centers for Disease Control and Prevention 7
• Considerar infecciones oportunistas en pacientes con VIH con recuentos de CD4 menos de 200 células/μL o en aquellos con recuentos más de 200 células/μL que presentan fiebre inexplicada, pérdida de peso o candidiasis oral, as suggested by the American College of Chest Physicians 8, 9

CD4 Count Thresholds and Opportunistic Infections in HIV/AIDS

Critical CD4 Thresholds for Specific Opportunistic Infections

• The Centers for Disease Control and Prevention recommends PCP prophylaxis should also be initiated if unexplained fever >100°F for ≥2 weeks or oropharyngeal candidiasis occurs, regardless of CD4 count 12

Infections That Occur at Any CD4 Level

• The Infectious Diseases Society of America notes that infections such as tuberculosis, herpes zoster, and pneumococcal infections can occur even with CD4 >200 cells/μL, and do not follow the typical pattern of severe immunosuppression-related opportunistic infections 13

Prophylaxis Regimens by CD4 Threshold

• The Centers for Disease Control and Prevention recommends first-line prophylaxis for PCP with TMP-SMX double-strength tablet three times weekly, which provides cross-protection against toxoplasmosis and many bacterial infections 12
• The Centers for Disease Control and Prevention also recommends alternative prophylaxis regimens, including dapsone 100 mg orally daily if TMP-SMX cannot be tolerated, and dapsone plus pyrimethamine plus leucovorin for toxoplasmosis coverage 12

Critical Considerations for Prophylaxis Management

• The Centers for Disease Control and Prevention recommends using the lowest CD4 count ever recorded (nadir CD4) to determine need for prophylaxis, not the most recent count elevated by antiretroviral therapy 12

Antiretroviral Therapy as Primary Prevention

• The Infectious Diseases Society of America notes that highly active antiretroviral therapy (HAART) reduces the risk of developing HIV-associated opportunistic infections and malignancies by restoring immune function 13